Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Alzheimer Disease - Robert Becker, Ezio Giacobini

Alzheimer Disease

From Molecular Biology to Theraphy
Buch | Hardcover
614 Seiten
1996
Birkhauser Boston Inc (Verlag)
978-0-8176-3879-5 (ISBN)
CHF 224,65 inkl. MwSt
This volume reviews the new potential treatments and research in the area of Alzheimer's disease. Topics discussed include: progress in the international harmonization of drug development guidelines for dementia drugs; bioethics and law; development of rating instruments; and the Reagan Foundation.
This volume reviews the new potential treatments and research in the area of Alzheimer's disease. Special attention is given to international developments in all fields relevant to new drug development. Topics discussed include: progress in the international harmonization of drug development guidelines for dementia drugs; bioethics and law; development of rating instruments; behavioural treatments; and the activities of the Reagan Foundation. The text integrates basic and clinical research findings, and provides evaluation of new approaches to therapy by world leaders in the field. The potential benefit for Alzheimer patients and families resulting from these research programmes, from molecular biology to clinical pharmacology, is reviewed and evaluated.

I. Pathological Basis of Therapy in Alzheimer’s Disease.- Criteria for the Diagnosis of Alzheimer’s Disease.- Neuropathology Of Alzheimer’s Disease.- Processing of Amyloid, Cytoskeletal Damage and Apolipoproteins.- Cell Death: Excitotoxins, Apoptosis And Hypometabolism.- Neurotrophins, Growth Factors and Neuroprotectors.- Animal Models.- II. The Cholinergic System in Brain.- Treatment of Alzheimer Disease.- Cholinesterase Inhibitors in Alzheimer Disease Treatment.- III. Nicotinic and Muscarinic Cholinergic Agonists.- Nicotinic Agonists.- Muscarinic Agonists and Antagonists.- The Potential of Antioxidant Therapy.- The Potential for Anti-Inflammatory Therapy.- IV. Development of New Therapies in Alzheimer Disease.- Design of Clinical Trials.- Advances in Assessment.- SPECT and PET.- Potential Markers of Disease Progression and Drug Efficacy in Alzheimer’s Disease.- Treatment of Behavioral and Psychosocial Disturbances.- V. Social Issue in Alzheimer Disease.- Legal and Ethical Issues.- Socio-Economic As pects of Alzheimer Disease Treatment.- International Harmonization of Drug Guidelines.- Research Priorities in Alzheimer Disease Treatment — An International Perspective.- Author Index.

Erscheint lt. Verlag 1.12.1996
Reihe/Serie Advances in Alzheimer Disease Therapy
Zusatzinfo XIV, 614 p.
Verlagsort Secaucus
Sprache englisch
Maße 155 x 235 mm
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Geriatrie
Medizin / Pharmazie Medizinische Fachgebiete Neurologie
Naturwissenschaften Biologie Genetik / Molekularbiologie
Naturwissenschaften Biologie Humanbiologie
Naturwissenschaften Biologie Zoologie
ISBN-10 0-8176-3879-2 / 0817638792
ISBN-13 978-0-8176-3879-5 / 9780817638795
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Gisela Mötzing; Susanna Schwarz

Buch | Softcover (2022)
Urban & Fischer in Elsevier (Verlag)
CHF 46,15
das gesamte Spektrum der Altersmedizin für Klinik und Praxis

von Jürgen M. Bauer; Clemens Becker; Michael Denkinger

Buch | Hardcover (2024)
Kohlhammer (Verlag)
CHF 259,95
Das Wichtigste für Ärztinnen und Ärzte aller Fachrichtungen

von Klaus Hager; Olaf Krause

Buch | Softcover (2021)
Urban & Fischer in Elsevier (Verlag)
CHF 51,80